Stay updated on Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial page.

Latest updates to the Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedSite revision updated from v3.4.2 to v3.5.0. No changes to the study details, eligibility, outcomes, or navigation are indicated.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check60 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check67 days agoChange DetectedAdded a glossary toggle, introduced a 'Last Update Submitted that Met QC Criteria' metadata item, and updated capitalization for FEAR data and the page revision to v3.4.0, all of which are UI/metadata refinements rather than changes to the core study content.SummaryDifference0.2%

- Check82 days agoChange DetectedA minor system revision shows Revision: v3.3.4 added and Revision: v3.3.3 removed, with no impact on study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check103 days agoChange DetectedAdded a consolidated Locations section listing Barcelona and Tarragona. The previous separate 'Barcelona Locations' and 'Tarragona Locations' headings have been replaced (revision: v3.3.3).SummaryDifference0.3%

Stay in the know with updates to Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial page.